Microbiome-Linked Metabolic Architecture of Accelerated Biological Aging in Humans
aging and disease · 2026
DOI: 10.14336/ad.2026.0237 ↗Kurz gefasst
Fachartikel in der Zeitschrift aging and disease, 2026. Verfasst von Mitsuru Yagi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, School of Medicine, International University of Health and Welfare, Chiba Japan. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Biological aging is a major determinant of frailty, functional decline, and vulnerability to age-related diseases; however, its upstream metabolic and inflammatory signatures remain incompletely understood. We investigated biological aging using an integrated multi-omics approach in a clinically enriched human cohort. In this prospective study, 120 patients with adult spinal deformity (ASD) and 480 age- and sex-matched healthy controls were included for comparison of PhenoAge. Within the ASD cohort, high-resolution plasma metabolomics and targeted proteomics were performed to characterize metabolic and inflammatory correlates of biological aging. A composite trimethylamine N-oxide (TMAO) Pathway Index (TPI) was constructed using standardized methylamine-related metabolites. Biological age was significantly elevated in ASD compared with matched controls. Within the ASD cohort, metabolomic profiling revealed enrichment of methylamine-related and glycation-associated metabolites among the strongest correlations of PhenoAge. The TPI showed a strong, age-independent, near-linear association with PhenoAge. In sensitivity analyses adjusted for age, sex, BMI, smoking status, and eGFR, this association remained significant (β = 2.92, 95% CI 0.74-5.10, p = 0.009). Targeted proteomic analyses showed that tumor necrosis factor-α was selectively associated with both PhenoAge and the TPI, whereas associations with interleukin-1β, interleukin-6, and adiponectin were limited. Higher PhenoAge was also associated with reduced physical performance, increased frailty, and impaired health-related quality of life. These findings support an exploratory, hypothesis-generating framework in which methylamine-related metabolism and chronic inflammatory signaling are associated with biological aging in ASD. Because of the cross-sectional design, these results should be interpreted as associative rather than causal.
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, School of Medicine, International University of Health and Welfare, Chiba Japan.
- Department of Orthopaedic Surgery, International University of Health and Welfare (IUHW) Narita Hospital, Chiba Japan.
- Department of Orthopaedic Surgery, International University of Health and Welfare (IUHW) Hospital, Tochigi Japan.
- Department of Public Health, Graduate School of Medicine, International University of Health and Welfare, Tokyo Japan.
Zitieren
APA
Yagi, M., Mizukoshi, R., Ito, K., Isogai, N., Funao, H., & Fujita, R. (2026). Microbiome-Linked Metabolic Architecture of Accelerated Biological Aging in Humans. aging and disease. https://doi.org/10.14336/ad.2026.0237
Vancouver
Yagi M, Mizukoshi R, Ito K, Isogai N, Funao H, Fujita R. Microbiome-Linked Metabolic Architecture of Accelerated Biological Aging in Humans. aging and disease. 2026. doi:10.14336/ad.2026.0237
BibTeX
@article{Yagi2026,
author = {Yagi, Mitsuru and Mizukoshi, Ryo and Ito, Keitaro and Isogai, Norihiro and Funao, Haruki and Fujita, Retsu},
title = {Microbiome-Linked Metabolic Architecture of Accelerated Biological Aging in Humans},
journal = {aging and disease},
year = {2026},
doi = {10.14336/ad.2026.0237}
}
EUVIMED